Skip to content

H.R. 2085 · 119th Congress (2025–2027)

Mental Health Research Accelerator Act of 2025

To amend the Internal Revenue Code of 1986 to provide for a credit against tax for expenses for translational research regarding neurodegenerative diseases and psychiatric conditions.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 2085’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Mike Thompson (D-CA-4)
Cosponsors
7 cosponsors

1 original · 6 later

1 R · 6 D

  1. Rep. Mike Kelly (R-PA-16)· Original · Mar 11, 2025
  2. Rep. John Garamendi (D-CA-8)· Later · Mar 21, 2025
  3. Rep. Shri Thanedar (D-MI-13)· Later · Mar 21, 2025
  4. Rep. André Carson (D-IN-7)· Later · Nov 17, 2025
  5. Rep. Andrea Salinas (D-OR-6)· Later · Nov 17, 2025
  6. Rep. Thomas R. Suozzi (D-NY-3)· Later · Feb 13, 2026
  7. Rep. Doris O. Matsui (D-CA-7)· Later · Apr 27, 2026
Policy area
Taxation

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Ways and Means.

    Sources

Committees

  1. HouseWays and MeansReferred Mar 11, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Mental Health Research Accelerator Act of 2025

    Display title, Short title · Introduced in House

  2. To amend the Internal Revenue Code of 1986 to provide for a credit against tax for expenses for translational research regarding neurodegenerative diseases and psychiatric conditions.

    Official title · Introduced in House